plachitin

03/01/1995 - "Local application of Plachitin improved the survival of mice previously implanted with Ehrlich tumor (p < 0.05). "
08/01/1992 - "When Plachitin was implanted around the solid tumor, the survival rates were improved and the gain in tumor weight was suppressed as compared with the controls. "
08/01/1993 - "From the above results it can be concluded that Plachitin particles released CDDP slowly around the tumor and the tumor growth was suppressed by the additive effect of CDDP and embolization. "
08/01/1993 - "Tumor regression was noticed only in the Plachitin group. "
08/01/1993 - "Plachitin was considered a useful agent for chemoembolization therapy for the cancer patients."

09/01/1995 - "[Pharmacokinetic study of intraperitoneally administered plachitin for non-curative gastrointestinal cancer]."
09/01/1995 - "Pharmacokinetics and adverse effects of Plachitin for intraperitoneal chemotherapy (IP) were studied in 11 patients who suffered from non-curative gastrointestinal cancers in comparison with 4 patients who underwent IP of CDDP. "

09/01/1995 - "Five patients were given 300 mg (100 mg as CDDP) of Plachitin which was cotton type on the residual cancer mass (Group A). "

08/01/1991 - "Anticancer effect of Plachitin was investigated by injecting 180 sarcoma cells in mouse peritoneal cavity and subsequent implantation of Plachitin. "

09/01/1994 - "Adverse effects of Plachitin particles for arterial chemoembolization were epigastralgia, nausea, fever, and elevation of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. "